-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Adaptive Biotechnologies Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to Q3 2025.
- Adaptive Biotechnologies Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 163M shares, a 10.6% increase year-over-year.
- Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 147M shares, a 1.88% increase from 2023.
- Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 144M shares, a 1.31% increase from 2022.
- Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 143M shares, a 1.54% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)